BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12802008)

  • 1. Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.
    Oganesian A; Poot M; Daum G; Coats SA; Wright MB; Seifert RA; Bowen-Pope DF
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7563-8. PubMed ID: 12802008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
    Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
    Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.
    Baran CP; Tridandapani S; Helgason CD; Humphries RK; Krystal G; Marsh CB
    J Biol Chem; 2003 Oct; 278(40):38628-36. PubMed ID: 12882960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
    Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates.
    Yu KR; Kim YJ; Jung SK; Ku B; Park H; Cho SY; Jung H; Chung SJ; Bae KH; Lee SC; Kim BY; Erikson RL; Ryu SE; Kim SJ
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1522-9. PubMed ID: 23897475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPRQ is a novel phosphatidylinositol phosphatase that can be expressed as a cytoplasmic protein or as a subcellularly localized receptor-like protein.
    Seifert RA; Coats SA; Oganesian A; Wright MB; Dishmon M; Booth CJ; Johnson RJ; Alpers CE; Bowen-Pope DF
    Exp Cell Res; 2003 Jul; 287(2):374-86. PubMed ID: 12837292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.
    Mahimainathan L; Choudhury GG
    J Biol Chem; 2004 Apr; 279(15):15258-68. PubMed ID: 14718524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
    Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
    Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity.
    Nandurkar HH; Caldwell KK; Whisstock JC; Layton MJ; Gaudet EA; Norris FA; Majerus PW; Mitchell CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9499-504. PubMed ID: 11504939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
    Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
    Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
    Kandasamy K; Srivastava RK
    Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.